FINWIRES · TerminalLIVE
FINWIRES

L3Harris Technologies' 2026 Outlook 'Incrementally Conservative' After Strong Q1, RBC Says

By

-- L3Harris Technologies' (LHX) 2026 outlook seems "incrementally conservative," given the strong Q1, with the company expected to raise guidance with its Q2 results, RBC Capital Markets said in a note emailed Friday.

For 2026, the company raised its earnings outlook to a range of $11.40 to $11.60 per share from $11.30 to $11.50. It continues to expect full-year revenue of $23 billion to $23.5 billion.

L3Harris' management sounded confident in the full-year revenue outlook and suggested the strong current momentum could lead to a 2026 guidance update with Q2 results, RBC analysts said. The company also indicated that the new chief financial officer's short tenure contributed to the decision not to raise guidance after the strong Q1, they added.

"We believe investors will continue to view the guide as conservative even after raising the revenue guide for 2026 after the Q4 2025 results," the analysts said.

The analysts said the company could benefit from mid-single-digit organic growth, while a stronger focus on execution should help support confidence in its 2026 margin targets. Improved capital allocation, including debt reduction, may also act as a positive catalyst, they said.

RBC maintained its sector perform rating and $365 price target on L3Harris.

Price: $314.10, Change: $-6.45, Percent Change: -2.01%

Related Articles

Australia

Novartis Gains Canada Nod for Fabhalta in Rare Kidney Disease

Novartis (NVS) said Health Canada has approved Fabhalta for the treatment of adults with complement 3 glomerulopathy (C3G), to reduce proteinuria.C3G is a rare, long-term kidney disease caused by an overactive immune pathway. This leads to a buildup of protein in the kidneys, causing inflammation, damage and, over time, loss of kidney function.The approval was backed by Phase III data showing a statistically significant reduction in proteinuria at six months, with sustained benefits through one year.Fabhalta (iptacopan) is an oral drug that blocks a key part of the immune system (Factor B), helping reduce the harmful activity that drives C3G and protects the kidneys.Price: $146.84, Change: $-1.01, Percent Change: -0.68%

$NVS
Research

Research Alert: CFRA Maintains Hold Rating On Shares Of Commvault Systems Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our target price to $106, from $101, on a forward P/E of 21x our FY 27 EPS estimate of $5.05, below its three-year average. We increase our FY 27 EPS projection to $5.05 from $4.80, and start our FY 28 EPS forecast at $5.90. CVLT reported solid Q4 results, above consensus views, with total revenue rising 13% Y/Y to $312M, fueled by subscription revenue growth of 20% to $208M and strong SaaS revenue contribution of $93M (+43% Y/Y). SaaS ARR rose 42% to $400M, while subscription ARR hit $989M, up 27% Y/Y, with net new ARR of $53M marking the strongest quarterly performance of FY26. Results reflect momentum in the business as CVLT benefits from data security challenges from AI use. We anticipate long-term tailwinds, but note greater macro and demand uncertainty in FY 27. We highlight impressive FCF generation (record $132M) and continued margin expansion expected in the new fiscal year.

$CVLT
Commodities

US Soybean Crush Rose in March, Stocks Tightened, USDA Says

The US Department of Agriculture on Friday reported that soybean crush for March rose above February and year-ago totals, but stocks dropped.In its monthly Oilseed Crushings, Production, Consumption and Stocks Report, the USDA pegged soybeans crushed for crude oil at 6.82 million metric tons, or 227 mb, in March 2026, compared with 6.43 million mt, or 214 mb, in February 2026, and 6.20 million mt, or 207 mb, in March 2025.The amount of crude oil produced from crushed soybeans was 2.64 billion pounds, up 6% from February 2026 and up 7% from March 2025.Production of soybean oil, once refined, totaled 2 billion pounds in March 2026, up 14% from February 2026 and 7% from March 2025.Iowa facilities crushed a total of 1.5 million mt, followed by facilities in the North and Eastern US, totaling 1.3 million mt.Soybean-based crude oil stocks, as of March 31, 2026, totaled 2 billion pounds, slightly below 2.1 billion in February.Corn oil crushed to produce crude oil totaled 139 million pounds in March, above 132.7 million pounds in February.